Developer of monoclonal antibodies designed to accelerate the discovery and development of next-generation antibody therapies. The company's platform partners with pharmaceutical and biotech for therapeutic antibody discovery and immune profiling, increasing the speed and efficiency of antibody discovery from natural immune responses of immunized animals and human patients, enabling new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.abcellera.com
Vancouver, BC, Canada
Founded in 2012Inaccurate data? Flag it here.
Open jobs at AbCellera